JADE BIOSCIENCES INC

Historical 13F Holders

Symbol
JBIO
CUSIP
008064206
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 008064206 since 12/18/2024, largest first.

Filer % of Class Filed
Fairmount Funds Management LLC 13D/A
20.0% 6/9/2026
Event 6/5/2026
FMR LLC 13G
14.7% 6/6/2025
Event 5/30/2025
Janus Henderson Group Ltd. 13G/A 10.6% 7/8/2026
Event 6/30/2026
Paradigm Biocapital Advisors LP 13G/A
9.5% 11/16/2026
Event 9/30/2026
Bellevue Group AG 13G/A
6.8% 11/16/2026
Event 9/30/2026
Franklin Templeton, Inc. 13G
6.0% 10/28/2026
Event 9/30/2026
Venrock Healthcare Capital Partners III, L.P. 13G/A
5.9% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G 5.2% 10/27/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Vanguard Group Inc 13G/A 4.2% 1/30/2026
Event 12/31/2025
Frazier Life Sciences Public Fund, L.P. 13G/A
4.2% 11/14/2025
Event 9/30/2025
RA Capital Management, L.P. 13G/A
2.9% 11/16/2026
Event 9/30/2026
Sofinnova Venture Partners X, L.P. 13D/A
0.3% 3/5/2026
Event 4/28/2025
TCG Crossover GP I, LLC 13G/A
0.2% 5/15/2025
Event 4/28/2025
Atlas Venture Fund XII, L.P. 13D/A
0.2% 4/30/2025
Event 4/28/2025
Deep Track Capital, LP 13G/A
0% 2/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 163 81.8 M $1.15B
2026 Q2 157 72.9 M $1.62B
2026 Q1 123 51.2 M $734M
2025 Q4 108 47.1 M $702M
2025 Q3 80 31.6 M $273M
2025 Q2 75 31.5 M $315M